Silver Book Fact

An experimental drug may help those women whose breast cancer worsens despite use of other therapies. The medicine was shown in studies to nearly double the time breast cancer was suppressed. It is also thought that it may cross the blood-brain barrier, suppressing the spread of breast cancer to the brain.

Pollack, Andrew. New Drug Holds Promise for Type of Breast Cancer. The New York Times. June 4 2006. http://www.nytimes.com/2006/06/04/health/04cancer.html?ex=1159329600&en=691f887bb3d95f4b&ei=5070

Reference

Title
New Drug Holds Promise for Type of Breast Cancer
Publication
The New York Times
Publication Date
June 4 2006
Authors
Pollack, Andrew
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • Cancer Survivors in the United States  
  • Since 1980, 83 percent of gains in life expectancy for cancer patients have been attributable to new treatments.  
  • Since 1975, the five year survival rate for breast cancer patients has increased by 40 percent.  
  • Cancer patients in the U.S. experience greater survival gains than those in European countries, and the value of additional gains exceeds the additional cost of care in the U.S.  
  • According to the Pharmaceutical Research and Manufacturers of America, one of the most promising medicines in development is for glioblastoma. The medicine singles out and latches onto the receptors on…